However, NGS methodology was used more frequently in recent publications from both clinical and molecular trials, suggesting an overall trend towards the newer sequencing method.
← all excerpts
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer.
2
—
—
The sentences
There is an increasing trend towards conducting clinical trials that test for the presence of genetic mutations up front (at initial diagnosis), yet this typically requires fresh tissue biopsies.